QUOIN PHARMACEUTICALS LTD: EXPECTS TO REPORT TOPLINE DATA IN Q2 OF 2027 FOR STUDY OF QRX003 IN NETHERTON SYNDROME

Reuters · 2d ago

Please log in to view news